Vaccines. Dr T. Espanol Immunology Unit University Hospital Vall d´ Hebron Barcelona. Effective vaccines: rapid decrease in infections in the general population.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Dr T. Espanol
University Hospital Vall d´ Hebron
For this reason it is so important to follow the immunisation programmes
until the infection can be considered erradicated
Measles cases / protection
Innate response / inflammation
Distribution and recirculation
recognise antigens in any part of the body and distribute effector
cells and antibodies throughout the organism
body and in lymph nodes they mature to produce antibodies or cytotoxic cells that leave the lymph nodes for any part of the body
Specific T-cell response
by monocyte/macrophages (through some receptors), and the presentation of antigens (part of the proteins) to the super-specific
Innate response/inflammation is essential to elicit a specific response
induce several effector mechanisms, collaborate with B cells to produce antibodies and secrete cytokines that mature cytotoxic cells, etc
(except red cells and the cornea) and their function is to recognise the “identity” of our cells versus foreign cells or cells with foreign antigens
Correlation between some HLA characteristics and diseases
The Fab segment is able to recognise many different antigens
Intracellular bacteria: tuberculosis
Viral infections : polio
Vaccines to prevent viral infections e.g. measles, polio, HIV must stimulate cytotoxic cells (T cells)
Most of them are very effective in healthy persons.
- HIV vaccine not achieved to date due to the extreme
variability of the virus and because it is a retrovirus
- Anti-’flu vaccines. Effective but the antigen must be
changed periodically due to changes in the virus
Vaccines against parasites (e.g. Malaria) very difficult to achieve Not much research has been done ( affects poor countries !!!)
Attenuated (“live “ vaccines) BCG, measles, chicken pox...
Inactivated most anti-bacterials, polio i.m., ‘flu...
Conjugated (polysaccharides and proteins) Haemophilus
Recombinant Hepatitis B
DNA vaccines under development
New vaccines :
Human Papilloma virus recombinant
specific microorganism that is infecting a patient with poor response
- Anti-tumour “vaccines”: Use of presenting cells with incorporated tumoral antigens to induce a stronger specific response
- Immunotherapy in allergic diseases: to inhibit specific IgE synthesis with small and repeated amounts of the allergen (tolerance)
Vaccines against bacteria are of no use in antibody deficiency
syndromes. In these cases, theoretically, vaccines against virus COULD (?) be given , but there is no way to know whether they are effective.
In any event, inactivated or recombinant vaccines should
ALWAYS be used !!!
- François G et al. Vaccine safety controversies and the future vaccination programs. Ped Infect Dis J 2005; 24(11) 953-61
- Ada, G. Vaccines and vaccination. N. Engl.J. Med 2001; 345: 1042-1053.
- Ljungman, P., Engelhard, D., de la Camara R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases working party of the EBMT. Bone Marrow Transplant 2005; 35: 737-46.
- Nachman S, Kim S, King J, et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 2003; 112: 66-73
- Witney, CG, Farley, MM, Hadler, J. et al Decline in Invasive Penumococcal Disease after the Introduction of Protein-Polysaccharide Conjugate Vaccine. N.Engl.J.Med 2003; 348: 1737-46